85 related articles for article (PubMed ID: 15265501)
1. Synthesis and biological evaluation of novel fluoro and iodo quinoline carboxamides as potential ligands of NK-3 receptors for in vivo imaging studies.
Bennacef I; Tymciu S; Dhilly M; Lasne MC; Debruyne D; Perrio C; Barré L
Bioorg Med Chem; 2004 Aug; 12(16):4533-41. PubMed ID: 15265501
[TBL] [Abstract][Full Text] [Related]
2. Lithiation of functionalized fluoroquinolines: synthesis of dihalo-2-phenylquinoline-4-carboxamides and in vitro evaluation as NK-3 receptor ligands for medical imaging studies.
Bennacef I; Tymciu S; Dhilly M; Mongin F; Quéguiner G; Lasne MC; Barré L; Perrio C
J Org Chem; 2004 Apr; 69(7):2622-5. PubMed ID: 15049675
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of halogenated naphthyridone carboxamides as potential ligands for in vivo imaging studies of substance P receptors.
Bagot-Guéret C; Le Bas MD; Tymciu S; Darabantu M; Emond P; Guilloteau D; Lasne MC; Wijkhuisen A; Barré L; Perrio C
Bioconjug Chem; 2003; 14(3):629-41. PubMed ID: 12757389
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors.
Cappelli A; Matarrese M; Moresco RM; Valenti S; Anzini M; Vomero S; Turolla EA; Belloli S; Simonelli P; Filannino MA; Lecchi M; Fazio F
Bioorg Med Chem; 2006 Jun; 14(12):4055-66. PubMed ID: 16495062
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).
Giardina GA; Raveglia LF; Grugni M; Sarau HM; Farina C; Medhurst AD; Graziani D; Schmidt DB; Rigolio R; Luttmann M; Cavagnera S; Foley JJ; Vecchietti V; Hay DW
J Med Chem; 1999 Mar; 42(6):1053-65. PubMed ID: 10090788
[TBL] [Abstract][Full Text] [Related]
6. Strategies for the labeling of halogen-substituted peroxisome proliferator-activated receptor gamma ligands: potential positron emission tomography and single photon emission computed tomography imaging agents.
Lee BC; Lee KC; Lee H; Mach RH; Katzenellenbogen JA
Bioconjug Chem; 2007; 18(2):514-23. PubMed ID: 17315977
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and receptor binding studies of halogenated N,N-dialkylel-(2-phenyl-1H-indol-3-yl)glyoxylamides to visualize peripheral benzodiazepine receptors with SPECT or PET.
Bennacef I; Haile CN; Schmidt A; Koren AO; Seibyl JP; Staley JK; Bois F; Baldwin RM; Tamagnan G
Bioorg Med Chem; 2006 Nov; 14(22):7582-91. PubMed ID: 16908169
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new 4-heteroaryl-2-phenylquinolines and their pharmacological activity as NK-2/NK-3 receptor ligands.
Borioni A; Mustazza C; Sestili I; Sbraccia M; Turchetto L; Del Giudice MR
Arch Pharm (Weinheim); 2007 Jan; 340(1):17-25. PubMed ID: 17206605
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 2-(4-biphenylyl)quinoline-4-carboxylate and carboxamide analogs. New human neurokinin-3 (hNK-3) receptor antagonists.
Saudi MN; Rostom SA; Fahmy HT; El Ashmawy IM
Arch Pharm (Weinheim); 2003 Jun; 336(3):165-74. PubMed ID: 12822182
[TBL] [Abstract][Full Text] [Related]
10. Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.
Blaney FE; Raveglia LF; Artico M; Cavagnera S; Dartois C; Farina C; Grugni M; Gagliardi S; Luttmann MA; Martinelli M; Nadler GM; Parini C; Petrillo P; Sarau HM; Scheideler MA; Hay DW; Giardina GA
J Med Chem; 2001 May; 44(11):1675-89. PubMed ID: 11356103
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological characterization of novel 2-quinolinecarboxamide ligands of the peripheral benzodiazepine receptors bearing technetium-99m or rhenium.
Cappelli A; Mancini A; Sudati F; Valenti S; Anzini M; Belloli S; Moresco RM; Matarrese M; Vaghi M; Fabro A; Fazio F; Vomero S
Bioconjug Chem; 2008 Jun; 19(6):1143-53. PubMed ID: 18510350
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 18F-labeled dopamine D3 receptor ligands as potential PET imaging agents.
Hocke C; Prante O; Löber S; Hübner H; Gmeiner P; Kuwert T
Bioorg Med Chem Lett; 2005 Nov; 15(21):4819-23. PubMed ID: 16139501
[TBL] [Abstract][Full Text] [Related]
13. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
[TBL] [Abstract][Full Text] [Related]
14. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and binding affinity of a fluorine-substituted peroxisome proliferator-activated gamma (PPARgamma) ligand as a potential positron emission tomography (PET) imaging agent.
Lee BC; Lee KC; Lee H; Mach RH; Katzenellenbogen JA
Bioconjug Chem; 2007; 18(2):507-13. PubMed ID: 17309226
[TBL] [Abstract][Full Text] [Related]
16. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.
Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A
Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350
[TBL] [Abstract][Full Text] [Related]
17. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of fluorine substituted pyrazolopyrimidines as potential leads for the development of PET-imaging agents for the GABAA receptors.
Hoepping A; Diekers M; Deuther-Conrad W; Scheunemann M; Fischer S; Hiller A; Wegner F; Steinbach J; Brust P
Bioorg Med Chem; 2008 Feb; 16(3):1184-94. PubMed ID: 18023192
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.
Plisson C; Stehouwer JS; Voll RJ; Howell L; Votaw JR; Owens MJ; Goodman MM
J Med Chem; 2007 Sep; 50(19):4553-60. PubMed ID: 17705359
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, radiolabeling, and in vitro and in vivo evaluation of bridgehead iodinated analogues of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as potential SPECT ligands for the 5-HT1A receptor.
Al Hussainy R; Verbeek J; van der Born D; Braker AH; Leysen JE; Knol RJ; Booij J; Herscheid JK
J Med Chem; 2011 May; 54(10):3480-91. PubMed ID: 21520940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
